Daily signal

Orchid Shows Parents Their Embryos’ Future Health Risks

“Have it your way” isn’t just for fast-food burgers anymore.

It’s also for babies.

Orchid, which labels itself as “the world’s most advanced whole genome screening for embryos during IVF,” was highlighted in a recent New York Times article headlined “This baby was carefully selected as an embryo.”

Orchid, writes journalist Anna Louie Sussman, “screens embryos’ DNA for hundreds of conditions” and also “offer[s] what is known as polygenic screening, which gives parents what is essentially a risk profile on each embryo’s propensity for conditions, such as heart disease.”

Read more…

Related Posts